Back to Search
Start Over
A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: a California Cancer Consortium Study.
- Source :
-
British journal of haematology [Br J Haematol] 2018 Feb; Vol. 180 (3), pp. 445-448. Date of Electronic Publication: 2016 Sep 21. - Publication Year :
- 2018
- Subjects :
- California
Humans
Myelodysplastic Syndromes diagnosis
Myelodysplastic Syndromes mortality
Receptors, Vascular Endothelial Growth Factor administration & dosage
Recombinant Fusion Proteins administration & dosage
Recombinant Fusion Proteins adverse effects
Treatment Outcome
Myelodysplastic Syndromes drug therapy
Receptors, Vascular Endothelial Growth Factor therapeutic use
Recombinant Fusion Proteins therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1365-2141
- Volume :
- 180
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- British journal of haematology
- Publication Type :
- Report
- Accession number :
- 27650362
- Full Text :
- https://doi.org/10.1111/bjh.14333